Alkem Laboratories Limited
ALKEM
Rank in Stocks
#2826
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Share Price
$55.22
Last synced: 2026-10-19
Market Cap
$6.60B
Change (1 day)
-1.29%
Change (1 year)
-12.67%
Country
IN
Trade Alkem Laboratories Limited (ALKEM)
Category
Healthcare
EPS for Alkem Laboratories Limited (ALKEM)
EPS as of June 2026 TTM: $1.99
According to Alkem Laboratories Limited latest financial reports and stock price the company's current EPS (TTM) is $1.99. At the end of 2024 the company had a EPS of $1.80 an increase over its 2023 EPS that were of $1.00.
EPS history for Alkem Laboratories Limited from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $1.99 | -6.17% |
| 2025 | $2.12 | 17.57% |
| 2024 | $1.80 | 79.83% |
| 2023 | $1.00 | -44.76% |
| 2022 | $1.81 | 0.12% |
| 2021 | $1.81 | 44.74% |
| 2020 | $1.25 | 36.59% |
| 2019 | $0.92 | 13.02% |
| 2018 | $0.81 | -29.55% |
| 2017 | $1.15 | 22.89% |
| 2016 | $0.94 | 78.39% |
| 2015 | $0.52 | -14.30% |
| 2014 | $0.61 | -19.80% |
| 2013 | $0.76 | 8.82% |
| 2012 | $0.70 | 15.60% |
| 2011 | $0.61 | 38.68% |
| 2010 | $0.44 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -72.03% |
IN
|
